Serum Creatinine and eGFR Where Are We Now? Dr Mike Bosomworth Lead Clinician - Blood Sciences Leeds Teaching Hospitals 16 th April 2013 1.

Slides:



Advertisements
Similar presentations
Assesment of renal function in case of near normal creatinine (<1
Advertisements

1. 2 ACEI inhibit angiotensin converting enzyme in the body. ACEI inhibit angiotensin converting enzyme in the body. Enzyme maintains balance between:
Group A Analgesic Nephropathy The Jaffe Method Enzymatic Assays
Chronic Kidney Disease/Dialysis Belinda Jim, MD January 15, 2009.
Myeloma and Renal Disease
CKD 1-5d GFR Stages Complications Referral Access/ESRD  Thomas Schumacher.
Selected Clinical Calculations
E XTRA CASE 2. PRESENTATION Ellen, 85 years, regular patient PC: nocturia disturbing her sleep HPC: happening for several weeks.
Kidney Function Tests Contents: Kidney functions Functional units Renal diseases Routine kidney function tests Serum creatinine Creatinine clearance.
Efficacy of Sodium Bicarbonate Infusion in Reversal of Acute Renal Failure 1 NEPHRO 2014 June 25-28, 2014 Valencia, Spain.
Kidney function, two complimentary evaluations Serum and urine testing Robert L. Stout, Ph.D.
Assessment of renal function Jack Shepard Jayne Windebank.
Kidney Function Tests Rana Hasanato, MD, KSFCB
Renal function.
Kidney Function Tests Contents: Functional units Kidney functions Renal diseases Routine kidney function tests Serum creatinine Creatinine clearance.
Renal Function Tests. Assessing the Kidney The Kidney The StructureThe Function Structure and function are not completely independent Some tests give.
Evaluation of the Modification of Diet in Renal Disease (MDRD) and Cockcroft-Gault (C-G) formulas in the Calvert equation for Carboplatin Dosing Whitney.
Renal Clearance The renal clearance of a substance is the volume of plasma that is completely cleared of the substance by the kidneys per unit time.
Creatinine and the eGFR Graham Jones Department of Chemical Pathology St Vincent’s Hospital, Sydney AACB-AIMS Annual Scientific meeting Hobart 2006.
Early Detection and Prevention of Renal Failure Linda Fried, MD, MPH.
Estimated GFR Based on Creatinine and Cystatin C
A significant proportion of diabetic patients develop diabetic nephropathy which can eventually progress to end-stage renal disease despite established.
6 / 5 / RENAL DISEASE OUTCOMES IN HYPERTENSIVE PATIENTS STRATIFIED INTO 3 GROUPS BY BASELINE GLOMERULAR FILTRATION RATE (GFR) ALLHAT.
The National Kidney Foundation’s Kidney Early Evaluation Program TM “The Greater New York Experience” Ellen H. Yoshiuchi, MPS Division Program Director.
Dose Adjustment in Renal and Hepatic Disease
... Assessing renal function in the elderly The development of a new Iohexol based method to measure the true Glomerular Filtration Rate Gijs Van Pottelbergh,
Ask Yourself! Can it be filtered? Is it reabsorbed? Is it secreted? What factors regulate the amount filtered, reabsorbed, and secreted? –Size –Permeability.
Creatinine methods and eGFR reporting in the SW and Wessex Region of the ACB Introduction The NSF for Renal Services recommends that for the NHS in England,
PLASMA CLEARANCE AND RENAL BLOOD FLOW
Kidney Function Tests. Kidney Function Tests Contents: Kidney functions Functional units Renal diseases Routine kidney function tests Serum creatinine.
Kidney Function Tests.
Estimation of Kidney Function Richard C. Walls
Laboratory Examination -clean midstream catch is usually adequate -in children,urine can be collected by placing a urine collection bag over the urethral.
Dr. Eman El Eter Renal Clearance. Concept of clearance Clearance is the volume of plasma that is completely cleared of a substance each minute. Example:
Practical Antibiotic Prescribing & Antibiotic Awareness Berny Baretto (Antibiotic Pharmacist) 21st November 2013.
2-4. Estimated Renal Function Estimated GFR = 1.8 x (Cs) x (age) Cockcroft-Gault eq. – Estimated creatine clearance (mL/min) = (140 – age x body weight,
Renal Clearance. Clearance
Diabetic nephropathy is a clinical syndrome.
Chapter 1: CKD in the General Population 2015 A NNUAL D ATA R EPORT V OLUME 1: C HRONIC K IDNEY D ISEASE.
Renal Physiology and Function Part II Renal Function Tests
Non-Protein Nitrogen (NPN) Compounds (Urea, Creatinine & Uric Acid)
Carboplatin and Creatinine Have we got it right?
© The Strategic Projects Team Hosted by the Greater East Midlands Commissioning Support Unit National Pathology Programme Standardisation and Harmonisation.
Renal Clearance. Renal clearance : It is the volume of plasma that is completely cleared of the substance by the kidneys per unit time. Renal clearance.
What is the Best Formula to Estimate GFR in Renal Allograft? Presenter: Ammar Qutub Supervisor: Prof.Abdallah Sayyari KSAU-HS College of Medicine.
Dr. Rida Shabbir DPT IPMR KMU 1. Objectives Describe the concept of renal plasma clearance Use the formula for measuring renal clearance Use clearance.
Lab (5): Renal Function test (RFT) (Part 2) T.A Nouf Alshareef T.A Bahiya Osrah KAU-Faculty of Science- Biochemistry department Clinical biochemistry lab.
Standardizing creatinine measurements – a pre-requisite for the routine reporting of eGFR HuQAS Annual Conference Nairobi, Kenya November 27, 2008.
Optimum Re 2015 Charlotte A. Lee, M.D., FLIM, DBIM EVALUATING RENAL FUNCTION.
ALLIE PUNKE PHARMCOKINETICS. KIDNEY FUNCTION FOR DRUG DOSING.
Ann Bugeja, MD FRCPC Integrative Lecture Week 1. You can access and use this PowerPoint presentation for educational purposes only. It is strictly forbidden.
CLINICAL APPLICATION OF UREA MEASUREMENTS METABOLIC ASPECTS OF KIDNEY METABOLISM.
Date of download: 6/22/2016 Copyright © The American College of Cardiology. All rights reserved. From: Choice of Estimated Glomerular Filtration Rate Equation.
Original article Chronic Renal Failure A Neglected Comorbidity of COPD Raffaele Antonelli Incalzi, MD; Andrea Corsonello, MD; Claudio Pedone, MD; Salvatore.
Charles Oo / ASCPT March 06 1 Repeated evaluation of the measured urinary creatinine clearance (CrCL), the predicted creatinine clearance based on Cockcroft-Gault.
Stephen R. Ash, MD, FACP IU Health Arnett Lafayette, Indiana 2017
Section 2: Detection of CKD
Figure 1.1 Prevalence of CKD by stage among NHANES participants,
Lab (5): Renal Function test (RFT) (Part 2)
Kidney Function Tests Dr Rana hasanato
Practical Analysis Using Spectrophotometer
From: A More Accurate Method To Estimate Glomerular Filtration Rate from Serum Creatinine: A New Prediction Equation Ann Intern Med. 1999;130(6):
Kidney Function Tests.
The MDRD Study.
Fig. 1. Distribution of eGFR according to baseline SCr
Pharmcokinetics Allie punke.
Renal Pharmacy Group Beginners Lectures 2018
Estimated Glomerular Filtration Rate From a Panel of Filtration Markers—Hope for Increased Accuracy Beyond Measured Glomerular Filtration Rate?  Lesley.
W. Greg Miller, Graham R.D. Jones  Advances in Chronic Kidney Disease 
Non-Protein Nitrogen (NPN) Compounds (Urea, Creatinine & Uric Acid)
Presentation transcript:

Serum Creatinine and eGFR Where Are We Now? Dr Mike Bosomworth Lead Clinician - Blood Sciences Leeds Teaching Hospitals 16 th April

2 Why measure serum creatinine?

3 RENAL CLEARANCE Substance cleared by renal excretion clearance (Cy ):- Cy = UyV Py (V = Urine flow rate) Substance freely filtered and excreted by glomerular filtration (i.e. not secreted) renal excretion determined by GFR and plasma concentration:- UyV = GFR x Py then GFR = UyV = Cy Py

Does Creatinine Clearance = Glomerular Filtration Rate? Is creatinine excreted by glomerular filtration alone (renal clearance = GFR)? Is creatinine filtered and secreted (renal clearance exceeds GFR)? Is creatinine filtered and reabsorbed (renal clearance less than GFR) 4

5 Equations for GFR Calculation Recommended equation ID-MS traceable abbrMDRD (Scr in umol/l) eGFR = 175 x (((Scr – intercept)/slope)x ) x Age x (0.742 if female) x (1.21 if African ) N.B. Most recent Schwartz Formula uses constant of 0.41 (IDMS calibrated enzymatic assay) CKD-EPI ?

6 Jaffe Reaction Creatinine + picric acid Orange-red (Janovski) complex 510 nm alkaline pH

7 Assay Interferences Jaffe Bilirubin (negative) Keto Acids Glucose and other metabolites Proteins Drugs

8 RENAL CLEARANCE Substance cleared by renal excretion clearance (Cy ):- Cy = UyV Py (V = Urine flow rate) Substance freely filtered and excreted by glomerular filtration (i.e. not secreted) renal excretion determined by GFR and plasma concentration:- UyV = GFR x Py then GFR = UyV = Cy Py

Jaffé Reaction - Modifications Kinetic – Interference Rapid – e.g. acetoacetate – within 20 secs Slow – e.g. protein – 80 – 100 secs Measure absorbance change between 20 and 80 secs Compensated – Interference Protein – adjust calibrator set point to take account of pseudo-creatinine contribution of protein i.e. subtract approx 27 umol/l Combination of the above 9

Jaffé Reaction – Modifications O’Leary + Kinetic 10

Enzymatic Creatinine One Method? 11

12 Assay Interferences Jaffe Bilirubin Keto Acids Glucose and other metabolites Proteins Drugs Enzymatic Drugs (fewer)

13

14 Jaffe M: Ueber den Neiderschlag, welchen Pikrinsaeure on normalen Harn erzeught and ueber eine neue Reaktion des Kretinins Z.Physiol.Che ;10:

15 C.V. = 6.0% C.V. = 12.4% Clinical Chemistry 52:15–18 (2006)

16 Clinical Chemistry 52:15–18 (2006)

Recommendations for Improving Serum Creatinine Measurement: A Report from the Laboratory Working Group of the National Kidney Disease Education Program – Clin Chem 2006;52:5-18 IVD manufacturers should recalibrate serum creatinine methods to be traceable to IDMS and should coordinate the introduction of recalibrated serum creatinine methods with the introduction of a revised GFR-estimating equation appropriate for use with zero-biased routine method 17

Certification of Creatinine in a Human Serum Reference Material by GC-MS and LC-MS Clin Chem 2007;53: SRM umol/L for serum pool 1 (a value close to the diagnostically important concentration of 88.4 umol/L) and umol/L for serum pool 2 (a concentration corresponding to that expected in a patient with chronic kidney disease). 18

19 WEQAS Creatinine Scheme Total no. Participants: 390

20 Method Bias Relative to Overall Mean (Distributions KG – KM)

Regional Oncology Unit 21

10 miles 22

Theoretical Differences using NEQAS Slopes and Intercepts (2010) Female, 45y, 55kgFemale, 75y, 60kg UK labs Creatinine 2 ( μ mol/l) C&G 3 (ml/min) Carboplatin 4 (mg) C&G 3 (ml/min) Carboplatin 4 (mg) Enzymatic5% Kinetic Jaffe - Abbott10% Kinetic Jaffe - Bayer4% Kinetic Jaffe - Dade Behring2% Kinetic Jaffe - Olympus12% Kinetic Jaffe - Compensated47% O'Leary7% Endpoint Jaffe2% Standardized Creatinine Variability 34% 26%34%24% 23

6 Jaffé and 3 Enzymatic West Yorks (10 samples) 24

Calculated Clearance / GFR vs Measured 25

Calculated vs Measured C-G CrCl using min SCr (ml/min) C-G CrCl using max SCr (ml/min) Wright eGFR using min Enz SCr (ml/min) Wright eGFR using max Enz SCr (ml/min) Wright eGFR using min Jaffe SCr (ml/min) Wright eGFR using max Jaffe SCr (ml/min) Min eGFR (ml/min) Max eGFR (ml/min) DTPA measured GFR (ml/min)

Carboplatin Dose Using Calvert (AUC = 6) 27

Carboplatin - Complications Too much – Bone marrow suppression Thrombocytopaenia – Bleeding Leucopaenia – Neutropaenia – Infections Anaemia Dose dependant Increased if prior therapy especially if also included cisplatin Too little – Decreased response 28

WEQAS Return (2012) MethodOverall Mean Overall Number VitrosMethod Mean Number11 Vitros ID-MS traceableMethod Mean Number17 16 EnzymaticMethod Mean Number Kinetic JaffeMethod Mean Number Jaffe - IDMSMethod Mean Number

NEQAS Return (2012) Overall Mean74.2CV8.2 Number543 Dry Slide (1)Mean71.4CV2.6 Number59 Comp. Kin. Jaffé (4)Mean73.7CV7.2 Number339 Trad. Kin. Jaffé (1)Mean83.3CV8.5 Number60 Enzymatic (2)Mean72.1CV3.8 Number134 LowestMean67CV2.8 HighestMean83.3CV8.5 30

Carboplatin Dose (AUC=6) 45 yr old women weighing 65 kg using C&G and Calvert formula Serum creatinine = 83 umol/L – Carboplatin dose = 612 mg Serum creatinine = 67 umol/L – Carboplatin dose = 726 mg True change serum creatinine and CrCL = 0 Change in dose = 116 mg = increase 19% 31

32 Effect of Change in Serum Creatinine Calibration on Prevalence of Low GFR in Nondiabetics in NHANES III. (Clase et al. J Am Soc Nephrol 2002;13: ) (i.e. uncalibrated – 20.3 umol/l) Lab used in Third National Health and Nutrition Examination Survey (NHANES) Results adjusted to method used in Modification of Diet in Renal Disease Study (MDRD) CKD CKD

Serum Creatinine and Calculated Creatinine Clearance / Estimated Glomerular Filtration Rate Survey 33

Assay + Instrument – Lab. 34 MethodNumber% (100) Manufacturer’s Jaffe34.8 Man. Kinetic Jaffe711.3 Man. Comp. Kinetic Jaffe34.8 Man. Enzymatic Man. Jaffe + Enz914.5 Manufacturer only Jaffe23.2 Kinetic Jaffe34.8 Compensated Jaffe11.6 Enzymatic58.1 Jaffe + Enz11.6 YES!11.6 Total62100 IDMS Traceable5791.9

Assay + Instrument - POCT 35 AnalyserNumberMethod Roche1? Nova3StatSensor Abaxix Piccolo1Enzymatic Total5 N/A36 Total Respondents41 No response21 IDMS Traceable2 Yes 5 No = 7!

Serum Creatinine and Calculated Creatinine Clearance / Estimated Glomerular Filtration Rate Survey 36

Adjustment Factors 37 Adjustment FactorsNumber umol/L1 -26 umol/L3 -11 umol/L1 Adjust if bilirubin high1 Total6 Yes8! No50 No response4

Serum Creatinine and Calculated Creatinine Clearance / Estimated Glomerular Filtration Rate Survey 38

cCrCl and / or eGFR labs calculated a creatinine clearance using serum and urine creatinine. No adjustment for height and weight Question was really looking to see if anyone was using C&G etc eGFR FormulaNumber MDRD with slope and intercept no slope and intercept Not stated8 Total50 One lab didn’t know whether they were using a slope and intercept (they were) and they were reporting eGFR to non-patients only

Serum Creatinine and Calculated Creatinine Clearance / Estimated Glomerular Filtration Rate Survey 40

41 ProfessionFormulaNumber OncologistsMDRD2 OncologistsC&G4 OncologistsWright (no CK)1 OncologistsMeasured CrCl1 OncologistNK1 PharmacistMDRD1 PharmacistC&G8 PharmacistSchwartz1 Paed TransplantSchwartz1 HaematologyC&G1 RenalMDRD1 DiabetesNK1 RadiologyNK1 DVT ServiceMDRD1 Not Known 21 Total46 Respondents36/62

Role of the Clinical Biochemist 42 Clinical biochemists in the UK are leading the way in promoting the contribution of laboratory medicine to healthcare Promoting the contribution of laboratory medicine Consultants in Clinical Biochemistry: The future – RCPATH/ACB Optimising knowledge management Recommendation: Consultants in charge of NHS clinical biochemistry departments should recognise the growing importance of knowledge management and take responsibility for ensuring implementation in a coordinated manner. ACB statement on laboratory assessment of kidney function –Nov Clinical users should be made aware that significant changes in estimated glomerular filtration rate might occur when a change in serum creatinine method is made. Examples of users likely to require well documented notification include renal physicians, oncologists, pharmacists, paediatricians and general practitioners

Healthcare Professionals Using SCr to Calculate CrCl and / or GFR and the Formula Used 43 SurveyNumber / Percent Respondents36 Don’t know21 Non respondents26 Don’t know47 Don’t know76% Do know24%

44 Serum Creatinine and eGFR Where Are We Now?

We need to be out there for the good of our profession, but much more importantly, to ensure optimum patient outcomes 45